3billion, Inc. (KOSDAQ:394800)
South Korea · Delayed Price · Currency is KRW 6,660.00
+90.00 (1.37%)
At close: Aug 4, 2025, 3:30 PM KST
3billion Company Description
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment.
It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers.
The company was founded in 2016 and is based in Seoul, South Korea.
3billion, Inc.
| Country | South Korea |
| Founded | 2016 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| CEO | Changwon Keum |
Contact Details
Address: 416 Teheran-ro Seoul, 06193 South Korea | |
| Website | 3billion.io |
Stock Details
| Ticker Symbol | 394800 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Changwon Keum | Chief Executive Officer |